Reviva Pharmaceuticals (RVPH) Institutional Ownership $1.01 -0.08 (-7.34%) Closing price 03/28/2025 04:00 PM EasternExtended Trading$1.06 +0.05 (+5.05%) As of 03/28/2025 07:34 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Reviva Pharmaceuticals (NASDAQ:RVPH)CurrentInstitutional OwnershipPercentage63.18%Number ofInstitutional Buyers(last 12 months)10TotalInstitutional Inflows(last 12 months)$868.93KNumber ofInstitutional Sellers(last 12 months)3TotalInstitutional Outflows(last 12 months)$1.06M Get RVPH Insider Trade Alerts Want to know when executives and insiders are buying or selling Reviva Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data RVPH Institutional Buying and Selling by Quarter Remove Ads Reviva Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/17/2025 Tang Capital Management LLC170,000$308K0.0%N/A0.508% 2/17/2025 Millennium Management LLC1,804,488$3.27M0.0%-1.5%5.396% 2/17/2025 Focus Partners Wealth60,000$109K0.0%-62.7%0.179% 2/17/2025 Cornerstone Select Advisors LLC17,500$32K0.0%N/A0.052% 2/17/2025 Ameriprise Financial Inc.46,467$84K0.0%N/A0.139% 2/14/2025 Schonfeld Strategic Advisors LLC1,058,100$1.92M0.0%-30.2%3.164% 2/14/2025 Tower Research Capital LLC TRC 26,775$48K0.0%+848.8%0.080% 2/13/2025 XTX Topco Ltd25,020$45K0.0%N/A0.075% 2/13/2025 Raymond James Financial Inc.14,000$25K0.0%N/A0.042% 2/12/2025 Geode Capital Management LLC311,701$564K0.0%+11.9%0.932% Get the Latest News and Ratings for RVPH and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Reviva Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 2/6/2025 Raymond James Financial Inc.14,000$25K0.0%N/A0.042% 1/23/2025 EMC Capital Management44,535$81K0.0%+142.0%0.133% 1/22/2025 Drive Wealth Management LLC20,000$36K0.0%N/A0.060% 11/16/2024 Geode Capital Management LLC278,496$401K0.0%+17.9%0.833% 5/10/2024 Vanguard Group Inc.1,001,836$3.79M0.0%+2.8%3.588% 2/13/2024 Armistice Capital LLC1,764,000$9.09M0.1%+194.0%6.318% 1/30/2024 Vontobel Holding Ltd.14,000$72K0.0%N/A0.062% 11/15/2023 Armistice Capital LLC600,000$2.93M0.0%-27.2%2.649% 11/9/2023 EMC Capital Management123,915$613K0.4%+1,294.3%0.547% 8/7/2023 Wolverine Asset Management LLC14,501$85K0.0%+137.6%0.071% 7/27/2023 Virtu Financial LLC18,448$108K0.0%N/A0.090% 2/15/2023 Tang Capital Management LLC24,125$103K0.0%N/A0.118% 2/13/2023 EMC Capital Management123,915$527K0.5%+125.0%0.606% 2/1/2023 Wolverine Asset Management LLC6,814$29K0.0%+934.0%0.033% 11/7/2022 Virtu Financial LLC46,119$73K0.0%N/A0.226% 10/25/2022Raymond James & Associates33,000$52K0.0%+65.0%0.161% 2/10/2022 EMC Capital Management55,078$159K0.1%-27.4%0.364% 2/3/2022 Northwestern Mutual Wealth Management Co.9,299$27K0.0%N/A0.067% 11/9/2021BlackRock Inc.33,470$136K0.0%+82.7%0.241% 8/17/2021 Armistice Capital LLC714,700$3.47M0.1%N/A7.742% 8/13/2021 Renaissance Technologies LLC11,250$55K0.0%N/A0.122% 8/13/2021 Northern Trust Corp10,584$51K0.0%N/A0.115% 8/13/2021 Geode Capital Management LLC67,724$329K0.0%N/A0.734% 8/13/2021 Vanguard Group Inc.529,464$2.57M0.0%N/A5.735% 7/28/2021 DAVENPORT & Co LLC10,000$49K0.0%-33.3%0.108% 5/21/2021 Citadel Advisors LLC36,652$210K0.0%N/A0.397% 5/18/2021 Millennium Management LLC35,310$203K0.0%N/A0.382% 5/18/2021 Citadel Advisors LLC36,652$210K0.0%N/A0.397% 4/28/2021 DAVENPORT & Co LLC15,000$86K0.0%N/A0.162% (Data available from 1/1/2016 forward)Remove Ads RVPH Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of RVPH shares? During the previous two years, 17 institutional investors and hedge funds held shares of Reviva Pharmaceuticals. The most heavily invested institutionals were Armistice Capital LLC ($9.09M), Vanguard Group Inc. ($3.79M), Millennium Management LLC ($3.27M), Schonfeld Strategic Advisors LLC ($1.92M), Geode Capital Management LLC ($564K), Tang Capital Management LLC ($308K), and Focus Partners Wealth ($109K).Learn more on RVPH's institutional investors. What percentage of Reviva Pharmaceuticals stock is owned by institutional investors? 63.18% of Reviva Pharmaceuticals stock is owned by institutional investors. Learn more on RVPH's institutional investor holdings. Which institutional investors have been buying Reviva Pharmaceuticals stock? Of the 14 institutional investors that purchased Reviva Pharmaceuticals stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Armistice Capital LLC ($1.16M), Tang Capital Management LLC ($170K), EMC Capital Management ($141.16K), Geode Capital Management LLC ($75.58K), Ameriprise Financial Inc. ($46.47K), Raymond James Financial Inc. ($28K), and Vanguard Group Inc. ($26.85K). How much institutional buying is happening at Reviva Pharmaceuticals? Institutional investors have bought a total of 1,779,382 shares in the last 24 months. This purchase volume represents approximately $7.65M in transactions. Which Reviva Pharmaceuticals major shareholders have been selling company stock? The following institutional investors have sold Reviva Pharmaceuticals stock in the last 24 months: Schonfeld Strategic Advisors LLC ($457.80K), Armistice Capital LLC ($224K), Focus Partners Wealth ($101K), and Millennium Management LLC ($28.33K). How much institutional selling is happening at Reviva Pharmaceuticals? Institutional investors have sold a total of 811,126 shares in the last 24 months. This volume of shares sold represents approximately $2.16M in transactions. Related Companies ZNTL Major Shareholders ACTU Major Shareholders OGI Major Shareholders DERM Major Shareholders ALEC Major Shareholders SAVA Major Shareholders LXEO Major Shareholders TELO Major Shareholders PRQR Major Shareholders GNLX Major Shareholders This page (NASDAQ:RVPH) was last updated on 3/30/2025 by MarketBeat.com Staff From Our PartnersWall Street’s “AI Oracle” Reveals Next Big Tech PlayA tiny American tech company could be at the center of the next big AI breakthrough. Wall Street's "AI Orac...InvestorPlace | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredPartner with Elon Musk on Project Colossus… Before May 1stEven though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks...Brownstone Research | SponsoredTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | SponsoredCrypto Genius: 12,000% in 12 months? [Here’s how]We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredThe Dirty Secret About Gold Mining Stocks...Here's something most gold analysts won't tell you: 90% of gold mining companies actually destroy sharehold...Golden Portfolio | SponsoredAI Boom Takes a Shocking Turn…A potentially historic moment for retirement Let's make the most of this market together. Crypto 101 Media | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Reviva Pharmaceuticals Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Reviva Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
